GYENNO Technologies

What GYENNO Technologies does

GYENNO Technologies CO., LTD. is a China-based digital health and medical technology company founded in 2013 and headquartered in Shenzhen, operating with 11-50 employees under the leadership of founder and CEO Kang Ren. The company focuses exclusively on central nervous system diseases, with Parkinson's Disease as its primary use case, and describes itself as having cultivated this field for 10 years. GYENNO serves both healthcare institutions and patients globally, distributing through a Global GYENNO platform, direct enterprise sales, and Amazon marketplace.

The company's core offering is a Next-generation Comprehensive Spatiotemporal Diagnosis and Treatment System structured around four proprietary platforms: TITAN (Medical and Engineering Research Platform supporting Digital Endpoint and Digital Academic Observational Trials), ZEUS (Intelligent Specialized Medical Center for clinical operations), PALLADIUM (Intelligent Patients Management with chronic disease monitoring), and HERCULES (Industrial Digital Intelligence Suite for healthcare operations). The portfolio also includes two medical device product lines, the BRAVO Series and SKYWALK Series, targeting Parkinson's Disease management. The underlying technology emphasizes cross-disciplinary integration of Medicine, Engineering, and Science.

GYENNO generates revenue primarily through hardware sales of medical devices and associated software platforms, with pricing not publicly disclosed. The go-to-market motion combines enterprise field sales to healthcare institutions (via direct email at [email protected]) with consumer/SMB distribution through Amazon, complemented by brand presence on Facebook and YouTube. Total disclosed funding to date is approximately $21.4M across rounds from 2014-2022, with Qiming Venture Partners, Eight Roads Ventures, and F-Prime among notable institutional investors.

Name

GYENNO Technologies

Legal name

GYENNO Technologies CO., LTD.

Website

https://gyenno.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

GYENNO Technologies is a Shenzhen-based medical technology company founded in 2013 that develops integrated diagnosis, treatment, and patient management platforms (TITAN, ZEUS, PALLADIUM, HERCULES) alongside BRAVO and SKYWALK medical devices for Parkinson's Disease and central nervous system patients globally.

Ownership category

akta.pro rank

Product category

Neurological Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Computer Systems Design and Related Services (5415)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Services-Health Services (8000)

akta.pro primary industry

Neurology Telemedicine Platforms (HLALAGAC)

akta.pro secondary industry

Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ)

Keywords

• Parkinson's disease management
• Neurological medical devices
• Central nervous system therapy
• Digital health platforms
• Spatiotemporal diagnosis systems

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Technology Solutions: Sale of medical devices and digital health solutions for Parkinson's Disease and central nervous system diseases, including BRAVO Series and SKYWALK Series products, along with associated software platforms (TITAN, ZEUS, PALLADIUM, HERCULES)

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

GYENNO Technologies develops and sells medical devices and integrated digital health platforms for the diagnosis and treatment of central nervous system diseases, with a primary focus on Parkinson's Disease. The offering combines hardware product lines (BRAVO Series and SKYWALK Series) with a comprehensive spatiotemporal diagnosis and treatment system built on four interconnected platforms: TITAN (research), ZEUS (specialized medical center), PALLADIUM (patient management), and HERCULES (industrial digital intelligence).

Product overview

GYENNO Technologies offers a unified platform-plus-modules architecture for Parkinson's Disease management. The core offering is the Next-generation Comprehensive Spatiotemporal Diagnosis and Treatment System, which integrates four platform modules: TITAN (Medical and Engineering Research Platform), ZEUS (Intelligent Specialized Medical Center), PALLADIUM (Intelligent Patients Management for chronic disease), and HERCULES (Industrial Digital Intelligence Suite). The portfolio also includes two product series — BRAVO Series and SKYWALK Series — which appear to be device or therapy product lines within this systemic medical solution ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

• BRAVO Series: Product line under the BRAVO Series, part of the company's medical device offerings.
• SKYWALK Series

Products and services

• BRAVO Series A product series under the GYENNO portfolio for Parkinson's Disease management, representing one of the company's medical device product lines for neurological disease treatment.
• SKYWALK Series A product series under the GYENNO portfolio for Parkinson's Disease management, representing one of the company's medical device product lines for neurological disease treatment.
• GYENNO Next-generation Comprehensive Spatiotemporal Diagnosis and Treatment System A comprehensive integrated system combining four platform modules—TITAN (Medical and Engineering Research Platform), ZEUS (Intelligent Specialized Medical Center), PALLADIUM (Intelligent Patients Management), and HERCULES (Industrial Digital Intelligence Suite)—for Parkinson's Disease diagnosis and treatment. Targets healthcare institutions, research organizations, and chronic disease management programs.

Segments1 record

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GYENNO Technologies